HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fred Zheng Selected Research

parsaclisib

12/2023A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204).
9/2023Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study.
8/2023Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fred Zheng Research Topics

Disease

5Neoplasms (Cancer)
09/2023 - 01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2023
1Lymphoma (Lymphomas)
12/2023
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2023
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Exanthema (Rash)
01/2023
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023
1Carcinogenesis
01/2023
1Hypophosphatemia
01/2023
1Carcinoma (Carcinomatosis)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2020
1Fatigue
01/2020
1Nausea
01/2020
1Disease Progression
02/2016
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2016

Drug/Important Bio-Agent (IBA)

3parsaclisibIBA
12/2023 - 08/2023
1Agammaglobulinaemia Tyrosine KinaseIBA
02/2024
1proto-oncogene proteins pimIBA
01/2023
1Azacitidine (5 Azacytidine)FDA Link
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023
1ruxolitinibIBA
01/2023
1pembrolizumabIBA
11/2022
1epacadostatIBA
11/2022
1Nuclear Proteins (Protein, Nuclear)IBA
01/2021
1INCB054329IBA
01/2020
1INCB057643IBA
01/2020
1fostamatinibIBA
02/2016
1Syk KinaseIBA
02/2016

Therapy/Procedure

2Therapeutics
01/2023 - 01/2020
2Drug Therapy (Chemotherapy)
01/2023 - 11/2022
1Immunotherapy
11/2022